49 Wealth Management’s AbbVie ABBV Stock Holding History

49 Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.73M	Buy	10,846 +4,487	+71%	+$965K	0.52%	45
2026 Q1	$1.38M	Buy	6,359 +326	+5%	+$72.3K	0.1%	55
2025 Q4	$1.38M	Buy	6,033 +380	+7%	+$86.6K	0.11%	55
2025 Q3	$1.31M	Sell	5,653 -1,454	-20%	-$296K	0.12%	49
2025 Q2	$1.32M	Buy	7,107 +497	+8%	+$92.4K	0.14%	46
2025 Q1	$1.38M	Buy	6,610 +1,307	+25%	+$254K	0.17%	49
2024 Q4	$942K	Buy	5,303 +301	+6%	+$55.3K	0.13%	56
2024 Q3	$988K	Buy	5,002 +3,458	+224%	+$645K	0.16%	56
2024 Q2	$263K	Buy	+1,544	New	+$256K	0.05%	123

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

49 Wealth Management's ABBV Position: Q2 2026 in Review

49 Wealth Management increased its AbbVie (ABBV) stake by 71% in Q2 2026, buying an estimated $965K and bringing the position to 10,846 shares worth $2.73M. The position accounts for 0.52% of the portfolio, ranked #45.

49 Wealth Management first reported a position in ABBV in Q2 2024 and has held it in 9 quarters since. 4,217 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

49 Wealth Management held 10,846 shares of AbbVie worth $2.73M as of Q2 2026.
49 Wealth Management bought 4,487 AbbVie shares in Q2 2026, an estimated $965K.
AbbVie made up 0.52% of 49 Wealth Management's portfolio in Q2 2026, its #45 holding.
49 Wealth Management first reported a position in AbbVie in Q2 2024 and has held it in 9 quarters since.
4,217 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on 49 Wealth Management's 13F filing for Q2 2026, filed 10 Aug 2026.